Yuko Oshima
Yuko Oshima has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Fumio Yamasaki
Department of Pathology Japan Community Health Care Organization, Saga Central Hospital Saga Japan
2 shared publications- Keisuke Tsumura
Department of Obstetrics and Gynecology, National Hospital Organization, Saga Hospital, Saga, Japan
2 shared publications Masatoshi Yokoyama
Department of Obstetrics and Gynecology Faculty of Medicine, Saga University Saga Japan
2 shared publicationsTakeshi Ono
Department of Obstetrics and Gynecology NHO Saga Hospital Saga Japan
2 shared publicationsYukiko Nakura
Department of Developmental Medicine Research Institute, Osaka Women's and Children's Hospital Osaka Japan
2 shared publicationsYutaka Kozuma
Department of Obstetrics and Gynecology NHO Saga Hospital Saga Japan
2 shared publications
Latest Publications
- 22 February 2026
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 52 (2) , e70220
Short‐Term Outcomes of Expectant Management With Antibiotics for Preterm Subclinical Intra‐Amniotic Infection
Aim: This study assessed the efficacy of expectant management with antibiotics in patients with intra‐amniotic infections diagnosed and treated at our institution. Antimicrobial and corticosteroid treatments were initiated for patients with intra‐amniotic inflammation and a high infection risk, and the diagnosis was confirmed 2 days later by culture results, including Ureaplasma spp. and Mycoplasma hominis , which guided further treatment. Methods: This retrospective cohort study included singleton pregnant women diagnosed with intra‐amniotic infection between 20 + 0 and 33 + 6 weeks of gestation between 2014 and 2021. Intra‐amniotic inflammation was defined as an interleukin‐6 concentration of ≥ 3.0 ng/mL in amniotic fluid, and intra‐amniotic infection was confirmed by positive amniotic fluid cultures combined with inflammation. First‐line antimicrobial therapy consisted of sulbactam/ampicillin and azithromycin. Primary outcome was the proportion of patients in which pregnancy was prolonged beyond 48 h without exacerbation of intra‐amniotic inflammation. Secondary outcome was prolonged pregnancy beyond 168 h. Results: Of 56 diagnosed patients, 45 were analyzed. Pregnancy was prolonged beyond 48 h without exacerbation in 71.9% of the women in a Ureaplasma spp./ Mycoplasma hominis ‐only group compared with 23.0% in the other bacterial group ( p = 0.006). Pregnancy was significantly prolonged beyond 168 h in the Ureaplasma spp./ Mycoplasma hominis ‐only group compared with that in the other bacterial group (28.1% vs. 0%, p = 0.04). Conclusions: Expectant management with antibiotics is feasible in the short term for subclinical intra‐amniotic infections caused solely by Ureaplasma spp./ Mycoplasma hominis . However, for cases caused by the other bacteria, further studies are needed to determine appropriate management strategies.
- 22 February 2026
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 52 (2) , e70220
Short‐Term Outcomes of Expectant Management With Antibiotics for Preterm Subclinical Intra‐Amniotic Infection
Aim: This study assessed the efficacy of expectant management with antibiotics in patients with intra‐amniotic infections diagnosed and treated at our institution. Antimicrobial and corticosteroid treatments were initiated for patients with intra‐amniotic inflammation and a high infection risk, and the diagnosis was confirmed 2 days later by culture results, including Ureaplasma spp. and Mycoplasma hominis , which guided further treatment. Methods: This retrospective cohort study included singleton pregnant women diagnosed with intra‐amniotic infection between 20 + 0 and 33 + 6 weeks of gestation between 2014 and 2021. Intra‐amniotic inflammation was defined as an interleukin‐6 concentration of ≥ 3.0 ng/mL in amniotic fluid, and intra‐amniotic infection was confirmed by positive amniotic fluid cultures combined with inflammation. First‐line antimicrobial therapy consisted of sulbactam/ampicillin and azithromycin. Primary outcome was the proportion of patients in which pregnancy was prolonged beyond 48 h without exacerbation of intra‐amniotic inflammation. Secondary outcome was prolonged pregnancy beyond 168 h. Results: Of 56 diagnosed patients, 45 were analyzed. Pregnancy was prolonged beyond 48 h without exacerbation in 71.9% of the women in a Ureaplasma spp./ Mycoplasma hominis ‐only group compared with 23.0% in the other bacterial group ( p = 0.006). Pregnancy was significantly prolonged beyond 168 h in the Ureaplasma spp./ Mycoplasma hominis ‐only group compared with that in the other bacterial group (28.1% vs. 0%, p = 0.04). Conclusions: Expectant management with antibiotics is feasible in the short term for subclinical intra‐amniotic infections caused solely by Ureaplasma spp./ Mycoplasma hominis . However, for cases caused by the other bacteria, further studies are needed to determine appropriate management strategies.
- 3 October 2025
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 51 (10) , e70100
Intra‐Amniotic Infection Prediction Score Based on Simple Maternal Information for Preterm Premature Rupture of Membranes
Aim: This study aimed to develop and validate a predictive model for intra‐amniotic infection in preterm premature rupture of membranes (PPROM) using simple maternal clinical parameters. Methods: A retrospective cohort study was conducted on pregnant women with PPROM between 22 + 0 and 35 + 6 weeks of gestation. The patients were categorized into development (2013–2017) and validation (2018–2023) cohorts. Intra‐amniotic infection was defined as the microbial invasion of the amniotic cavity with intra‐amniotic inflammation. Results: In total, 229 patients were analyzed, with 121 and 108 patients in the development and validation cohorts, respectively. A scoring system was established, assigning 1 point for gestational age of < 32 weeks and white blood cell (WBC) count of ≥ 11 400/μL, and 3 points for C‐reactive protein (CRP) level of ≥ 0.51 mg/dL. The areas under the receiver operating characteristic curve were 0.92 (95% confidence interval [CI], 0.87–0.98) and 0.86 (95% CI, 0.75–0.97) in the development and validation cohorts, respectively. The mean predicted probabilities were 2.6%, 8.7%, 24.9%, 53.6%, 80.1%, and 93.3% at scores of 0, 1, 2, 3, 4, and 5, respectively. The difference between the predicted and observed probabilities remained within 10% for all scores except for 3. Conclusions: A predictive score for intra‐amniotic infection in PPROM was developed and validated using the WBC count, CRP level, and gestational age, demonstrating high diagnostic accuracy. Further validation in diverse populations is necessary for broader clinical applicability.
- 3 October 2025
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 51 (10) , e70100
Intra‐Amniotic Infection Prediction Score Based on Simple Maternal Information for Preterm Premature Rupture of Membranes
Aim: This study aimed to develop and validate a predictive model for intra‐amniotic infection in preterm premature rupture of membranes (PPROM) using simple maternal clinical parameters. Methods: A retrospective cohort study was conducted on pregnant women with PPROM between 22 + 0 and 35 + 6 weeks of gestation. The patients were categorized into development (2013–2017) and validation (2018–2023) cohorts. Intra‐amniotic infection was defined as the microbial invasion of the amniotic cavity with intra‐amniotic inflammation. Results: In total, 229 patients were analyzed, with 121 and 108 patients in the development and validation cohorts, respectively. A scoring system was established, assigning 1 point for gestational age of < 32 weeks and white blood cell (WBC) count of ≥ 11 400/μL, and 3 points for C‐reactive protein (CRP) level of ≥ 0.51 mg/dL. The areas under the receiver operating characteristic curve were 0.92 (95% confidence interval [CI], 0.87–0.98) and 0.86 (95% CI, 0.75–0.97) in the development and validation cohorts, respectively. The mean predicted probabilities were 2.6%, 8.7%, 24.9%, 53.6%, 80.1%, and 93.3% at scores of 0, 1, 2, 3, 4, and 5, respectively. The difference between the predicted and observed probabilities remained within 10% for all scores except for 3. Conclusions: A predictive score for intra‐amniotic infection in PPROM was developed and validated using the WBC count, CRP level, and gestational age, demonstrating high diagnostic accuracy. Further validation in diverse populations is necessary for broader clinical applicability.